Transcranial electrical stimulation and pharmacological interventions in Autism Spectrum Disorder

Phase 3

• Conditions: Autism.; Autistic disorder; F84.0

• Registration Number: IRCT20190917044793N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Diagnosis of autism spectrum disorder by a child psychiatrist
being 6-16 years old
required written iformed consent signed by parents

Exclusion Criteria

comorbidity with other neurodevelopmental disorders and neurological diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score in the Gilliam autism rating scale. Timepoint: before intervention and 5, 10 , 30 and 90 days after intervention. Method of measurement: Gilliam autism rating scale.;Performance in the verbal fluency task. Timepoint: before intervention and 5, 10 , 30 and 90 days after intervention. Method of measurement: Verbal fluency task.;Score in the theory of mind test. Timepoint: before intervention and 5, 10 , 30 and 90 days after intervention. Method of measurement: Theory of Mind Test (ToMT).